Literature DB >> 25659385

[Psoriasis vulgaris in children and adolescents. Pathogenesis, clinical picture and therapy].

P H Höger1, H Hamm.   

Abstract

BACKGROUND: The prevalence of psoriasis vulgaris in childhood ranges from 0.12 % in infants to 1.2 % in adolescents. Psoriasis is a polygenic disease triggered by external factors and is influenced by comorbidities such as obesity, metabolic syndrome, chronic inflammatory bowel diseases and rheumatic diseases. CLINICAL FEATURES: Its clinical presentation is variable. Typical complications include erythroderma, disseminated pustulosis and arthropathy. THERAPY: Amongst a wide range of topical or systemic therapeutical options, individualized treatment is based on severity, site and extent of cutaneous involvement, age, potential side-effects and comorbidities.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25659385     DOI: 10.1007/s00105-015-3585-1

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  48 in total

1.  Improvement of psoriasis after tonsillectomy is associated with a decrease in the frequency of circulating T cells that recognize streptococcal determinants and homologous skin determinants.

Authors:  Ragna Hlin Thorleifsdottir; Sigrun Laufey Sigurdardottir; Bardur Sigurgeirsson; Jon Hjaltalin Olafsson; Martin Ingi Sigurdsson; Hannes Petersen; Sigurlaug Arnadottir; Johann Eli Gudjonsson; Andrew Johnston; Helgi Valdimarsson
Journal:  J Immunol       Date:  2012-04-09       Impact factor: 5.422

2.  Paediatric-onset psoriasis is associated with ERAP1 and IL23R loci, LCE3C_LCE3B deletion and HLA-C*06.

Authors:  J G M Bergboer; A M Oostveen; M E A de Jager; M den Heijer; I Joosten; P C M van de Kerkhof; P L J M Zeeuwen; E M G J de Jong; J Schalkwijk; M M B Seyger
Journal:  Br J Dermatol       Date:  2012-10       Impact factor: 9.302

3.  Obesity in early adulthood as a risk factor for psoriatic arthritis.

Authors:  Razieh Soltani-Arabshahi; Bob Wong; Bing-Jian Feng; David E Goldgar; Kristina Callis Duffin; Gerald G Krueger
Journal:  Arch Dermatol       Date:  2010-07

Review 4.  [Children and adolescents with psoriasis. What therapy is recommended?].

Authors:  M Sticherling
Journal:  Hautarzt       Date:  2012-03       Impact factor: 0.751

5.  Risks of developing psychiatric disorders in pediatric patients with psoriasis.

Authors:  Alexa B Kimball; Eric Q Wu; Annie Guérin; Andrew P Yu; Magda Tsaneva; Shiraz R Gupta; Yanjun Bao; Parvez M Mulani
Journal:  J Am Acad Dermatol       Date:  2012-01-13       Impact factor: 11.527

6.  Juvenile psoriasis in European and Asian children: similarities and differences.

Authors:  L Y T Chiam; M E A de Jager; Y C Giam; E M G J de Jong; P C M van de Kerkhof; M M B Seyger
Journal:  Br J Dermatol       Date:  2011-03-21       Impact factor: 9.302

7.  A cross-sectional study using the Children's Dermatology Life Quality Index (CDLQI) in childhood psoriasis: negative effect on quality of life and moderate correlation of CDLQI with severity scores.

Authors:  M E A de Jager; P C M van de Kerkhof; E M G J de Jong; M M B Seyger
Journal:  Br J Dermatol       Date:  2010-11       Impact factor: 9.302

8.  Systemic treatment with fumaric acid esters in six paediatric patients with psoriasis in a psoriasis centre.

Authors:  Kirsten Steinz; Sascha Gerdes; Silja Domm; Ulrich Mrowietz
Journal:  Dermatology       Date:  2014-09-19       Impact factor: 5.366

9.  Juvenile generalized pustular psoriasis.

Authors:  Ting Xiao; Bo Li; Chun-Di He; Hong-Duo Chen
Journal:  J Dermatol       Date:  2007-08       Impact factor: 4.005

10.  The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004.

Authors:  Shanu Kohli Kurd; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2008-11-20       Impact factor: 11.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.